Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis. (2022)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1212/wnl.0000000000200604
PubMed Identifier: 35321926
Publication URI: http://europepmc.org/abstract/MED/35321926
Type: Journal Article/Review
Volume: 98
Parent Publication: Neurology
Issue: 18
ISSN: 0028-3878